Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -202,244 | -83,948 | -32,811 | -31,154 | -26,388 |
| Depreciation Amortization | 471 | 112 | 96 | 77 | N/A |
| Accounts receivable | N/A | N/A | N/A | N/A | 7 |
| Accounts payable and accrued liabilities | -161 | -1,309 | 558 | 917 | -128 |
| Other Working Capital | 23,482 | 19,453 | -6,281 | 5,506 | -1,106 |
| Other Operating Activity | 20,891 | 24,068 | 12,931 | 2,337 | 10,007 |
| Operating Cash Flow | $-157,561 | $-41,624 | $-25,507 | $-22,317 | $-17,608 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 160,114 | 30,879 | -380,054 | -21,881 | 15,366 |
| PPE Investments | -334 | -172 | -22 | -125 | 695 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 5,849 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 83 |
| Investing Cash Flow | $159,780 | $30,707 | $-380,076 | $-22,006 | $21,993 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | N/A | N/A | 8,500 |
| Common Stock Issued | 5,088 | 235 | 314,335 | 173,805 | 5,954 |
| Financing Cash Flow | $5,088 | $235 | $314,335 | $173,805 | $14,454 |
| Beginning Cash Position | 46,697 | 57,379 | 148,627 | 19,145 | 306 |
| End Cash Position | 54,004 | 46,697 | 57,379 | 148,627 | 19,145 |
| Net Cash Flow | $7,307 | $-10,682 | $-91,248 | $129,482 | $18,839 |
| Free Cash Flow | |||||
| Operating Cash Flow | -157,561 | -41,624 | -25,507 | -22,317 | -17,608 |
| Capital Expenditure | -334 | -172 | -22 | -125 | -3 |
| Free Cash Flow | -157,895 | -41,796 | -25,529 | -22,442 | -17,611 |